Clinical Assessment: 65F with BP 180/74, TSH 12.4, Facial & Pedal Edema

Diagnosis

1. Myxedematous edema — facial puffiness + pedal swelling
2. Hypothyroid-induced hypertension — predominantly diastolic elevation pattern

Pathophysiology

Why Edema?

"Myxedema is the term describing the edema-like skin that results from deposition of glycosaminoglycans within the dermis. This appears as nonpitting cutaneous edema with firm texture and a pale waxy appearance. Facial puffiness…" — Tietz Textbook of Laboratory Medicine

Why Hypertension?

• Increased systemic vascular resistance → raised diastolic BP
• Reduced cardiac output and heart rate
• 20–40% of hypothyroid patients have hypertension, primarily diastolic

"A total of 20–40% of patients with hypothyroidism have hypertension, with the diastolic pressure being increased more than the systolic. This is primarily attributable to the increase in systemic vascular resistance." — Tietz Textbook of Laboratory Medicine

"Increased peripheral vascular resistance and low cardiac output…" — Rosen's Emergency Medicine

Key Investigations to Consider

Management

1. Levothyroxine (LT4) — Primary Treatment

"Elderly patients may require 20% less thyroxine than younger patients. In the elderly, especially patients with known coronary artery disease, the starting dose of LT4 is 12.5–25 μg/day with similar increments every 2–3 months until TSH is normalized." — Harrison's Principles of Internal Medicine 22E (2025)

• Start at 25 μg/day (cautious start given age, hypertension, possible silent CAD)
• Titrate by 12.5–25 μg increments every 6–8 weeks, guided by TSH
• Target TSH: normal range (0.5–4.0 mIU/L), ideally lower half
• Take on empty stomach, 30–60 min before breakfast

2. Hypertension Management

• Monitor BP after 6–8 weeks of LT4 therapy
• If BP remains elevated after achieving euthyroid state → add antihypertensives
• Preferred agents in hypothyroid-associated hypertension:
  • ACE inhibitors or ARBs (first-line, especially if any proteinuria or LV dysfunction)
  • Dihydropyridine CCBs (amlodipine) — good for isolated systolic hypertension in elderly
  • Avoid beta-blockers as first-line (can worsen bradycardia and mask hypothyroid symptoms)

3. Edema

• The myxedematous edema will resolve with euthyroidism — diuretics are not indicated and may be harmful (dehydration, electrolyte imbalance)
• Symptomatic relief with leg elevation if needed

Monitoring Plan

Summary

Short Answer: No — diuretics should NOT be started for this patient's edema.

The Edema is Myxedematous, Not Fluid Overload

"Myxedema is the term describing the edema-like skin that results from deposition of glycosaminoglycans (e.g., hyaluronic acid) within the dermis. This appears as nonpitting cutaneous edema with firm texture and a pale waxy appearance." — Tietz Textbook of Laboratory Medicine

Diuretics Would Actually Cause Harm Here

• Decreased GFR and renal blood flow
• Inappropriately elevated ADH (vasopressin) levels — an SIADH-like state

"Total-body water has been shown to increase in patients with hypothyroidism owing to impaired renal excretion of water. Although exchangeable body sodium is increased, the dilutional effect leads to a mild hyponatremia. Plasma vasopressin concentrations have been reported to be inappropriately increased." — Tietz Textbook of Laboratory Medicine

What To Do Instead

Review of Your Prescription

✅ Telmisartan 40 mg OD — Appropriate

• Hypothyroid hypertension is driven by increased vascular resistance (RAAS-mediated vasoconstriction plays a role) — ARBs directly counter this
• Renoprotective — normal renal function now, but hypothyroidism reduces GFR; ARBs protect going forward
• Telmisartan specifically has the longest half-life among ARBs (24h) and additional PPAR-γ agonist activity — good for once-daily compliance in elderly
• Well tolerated — no cough (unlike ACE inhibitors), no reflex tachycardia
• 40 mg is a sensible starting dose — can uptitrate to 80 mg if BP not controlled at 6–8 weeks

One note: Check baseline potassium and creatinine before starting and again at 2 weeks — ARBs can cause mild hyperkalemia and a small rise in creatinine (acceptable up to 30% rise).

✅ Amlodipine 5 mg OD — Appropriate

• Isolated systolic hypertension in elderly (BP 180/74, wide pulse pressure) responds particularly well to CCBs
• Amlodipine + ARB combination is one of the most evidence-backed antihypertensive combinations (ACCOMPLISH trial equivalent pairing)
• No negative chronotropy — safe with the underlying bradycardia of hypothyroidism
• Can uptitrate to 10 mg if needed

One note: Peripheral edema is a common side effect of amlodipine (dose-dependent, occurs in ~10% at 5 mg, ~30% at 10 mg). In this patient who already has facial and pedal edema, it may be difficult to assess whether edema is resolving with LT4 or worsening with amlodipine. Document baseline edema clearly so you can track the trend.

⚠️ Levothyroxine 50 µg — Slightly High for Her Age

"In the elderly, especially patients with known coronary artery disease, the starting dose of LT4 is 12.5–25 µg/day with increments every 2–3 months until TSH is normalized."

Complete Monitoring Plan

Summary

Revised Assessment

• She is not newly diagnosed — she is on treatment but under-replaced
• Jumping to 50 µg is now completely justified — you are simply correcting inadequate replacement, not starting from scratch
• The standard caution about "starting low in elderly" applies to initiation, not to dose escalation in an already-treated patient

Why Was She Under-Replaced on 25 µg?

Dosing Going Forward

• 50 µg is the right next step — standard increment is 25 µg at a time
• Recheck TSH in 6–8 weeks
• If TSH still elevated at 6–8 weeks → increase to 75 µg
• Target TSH: 0.5–2.5 mIU/L (lower half of normal range is preferred in symptomatic patients)

Take LT4 on an empty stomach, 30–60 minutes before breakfast, with plain water only — especially important to emphasise since she may not have been doing this on her 25 µg dose.

Key Point on Her BP